Dr. Gazmuri is Professor (tenure-track) in the Department of Medicine (primary appointment) and in the Department of Physiology & Biophysics (secondary appointment). Dr. Gazmuri is also Director of the Resuscitation Institute at RFUMS where he leads basic and translational research on acute life-threatening conditions including cardiac arrest and various forms of circulatory shock with focus on bioenergetic function and identifying novel therapeutic approaches. At the Captain James A. Lovell Federal Health Care Center (FHCC), Dr. Gazmuri is the Section Chief of Critical Care Medicine and ICU Director.
Dr. Gazmuri obtained his Medical Degree and Internal Medicine training from the University of Chile and practiced Critical Care Medicine before travelling to the United States in 1986 for a research fellowship at today’s RFUMS under the mentorship of late Professor Max Harry Weil, MD, PhD (one of the founding fathers of Critical Care Medicine). Dr. Gazmuri devoted three years as a full-time research fellow and five additional years as a Critical Care Fellow, PhD student, and junior faculty under Dr. Weil’s mentorship. In 1994, he earned a PhD degree in Physiology & Biophysics from RFUMS and in 1997 he was inducted Fellow of the American College of Critical Care Medicine.
Dr. Gazmuri has contributed to the field of Resuscitation and Critical Care Medicine with more than 200 publications and has received – as primary and/or senior author – multiple awards at national scientific meetings. He has served as member of the Basic Life Support, Advanced Life Support, Scientific Subcommittee of the Emergency Cardiovascular Care at the American Heart Association (AHA), and as member of the organizing committee of the AHA Resuscitation Science Symposium. He has also served on the International Liaison Committee on Resuscitation (ILCOR) involved in the development of CPR Guidelines and frequently participates on NIH and VHA Study Section panels.
In 2017, Dr. Gazmuri founded Resuscitation Therapeutics, Inc. with the goal of facilitating clinical translation of new therapies and strategies for life-threatening medical emergencies occurring in pre-hospital and hospital environments.
Listed below are publications from 2020 onwards. A complete list of original peer-reviewed publications is available at (maintained by the US National Library of Medicine).
2022-2025 | Project: Attenuation of Reperfusion Injury by Gliflozins During Cardiac Arrest Leading to Improved Post-Resuscitation Myocardial Function and Survival Source: BLR&D Merit Review Award (I01BX005705) Role: Principal Investigator |
2024-2025 | Project: Self-Operating System for Circulatory Management of Sepsis, Severe Sepsis, and Septic Shock Source: DePaul-RFUMS Pilot Grant Project Role: Co-Principal Investigator (conducting experiments at the Resuscitation Institute). |
2024-2025 | Project: Does Selective Peripheral α2-Adrenoceptor Stimulation during Cardiac Resuscitation Improves Survival with Favorable Neurologic Outcome Compared to Epinephrine? Source: Monica Ply Research Innovation Award Role: Principal Investigator |
2024-2026 | Project: Selective Targeting of Peripheral α2-Adrenoceptors with α-Methylnorepinephrine as a Superior Alternative to Epinephrine for Resuscitation from Cardiac Arrest Sponsor: ZOLL Foundation, Inc. Duration: 24 months Role: Mentor Principal Investigator: Armin Razi, MD, Research Fellow in the Resuscitation Institute at 无码群交 of Medicine and Science. |
2024-2026 | Project: Optimizing the Hemodynamic Management of Septic Shock by Continuous Monitoring of Microcirculatory Parameters Sponsor: ZOLL Foundation, Inc. Duration: 24 months Role: Mentor Principal Investigator: Moaz Bin Saeed, MBBS, Research Fellow in the Resuscitation Institute at 无码群交 of Medicine and Science. |